全球放射腫瘤學市場

預計到 2030 年全球放射腫瘤學市場規模將達到 102 億美元

全球放射腫瘤學市場規模預計在2024年達到79億美元，預計在2024-2030年的分析期間將以4.3%的複合年成長率成長，到2030年將達到102億美元。體外放射線治療是本報告分析的細分市場之一，預計其複合年成長率為3.3%，到分析期結束時規模將達到36億美元。近距離放射治療細分市場在分析期間的複合年成長率預計為5.5%。

美國市場預計將達到 22 億美元，中國市場複合年成長率將達到 7.6%

美國放射腫瘤學市場規模預計2024年達到22億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到21億美元，在2024-2030年的分析期間內，複合年成長率為7.6%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為1.8%和3.3%。在歐洲，預計德國市場的複合年成長率為2.5%。

全球放射腫瘤學市場—主要趨勢與促進因素摘要

放射腫瘤學如何發展以滿足癌症治療的需求？

放射腫瘤學仍然是癌症多學科治療的基石，技術創新不斷提高針對惡性組織的療效和精確度。該領域正在經歷從傳統放射治療向強度調控放射治療(IMRT)、立體定位放射線手術(SRS)、影像導航放射治療(IGRT) 和質子治療等先進技術的重大轉變。這些治療方法能夠精準輸送劑量，保護周圍健康組織，減少副作用，並改善患者預後。全球癌症發生率的上升和人口老化迫使醫療保健系統擴展其放射腫瘤學基礎設施和能力。

個人化腫瘤治療（根據腫瘤基因和放射學數據客製化治療方案）的採用正在進一步重新定義治療計劃。人工智慧和機器學習演算法與放射腫瘤學軟體的整合促進了自適應放射治療，該療法可根據患者反應和解剖變異即時調整治療方案。此外，放射生物學和低分割通訊協定的進步使得縮短治療時間並保持同等或更高的療效成為可能，從而提高了治療量並方便了患者。這些發展正在推動全球放射腫瘤學中心的臨床和營運轉型。

哪些技術和模式正在塑造現代放射腫瘤學實踐？

直線加速器、質子治療機、近距離放射治療設備和機器人放射放射線手術平台正日益受到關注。直線加速器系統現已整合多葉準直器 (MLC)、容積調強弧形治療 (VMAT) 和機載成像技術，能夠以更少的治療次數實現精準的腫瘤標靶治療。質子治療將大部分能量聚焦於布拉格峰，最大限度地減少附帶損傷並降低長期毒性，在兒童癌症和複雜腫瘤病例中正迅速獲得認可。

此外，諸如呼吸門控和即時腫瘤追蹤等運動管理技術正被納入治療方案，以應對治療過程中的器官運動問題，尤其是在肺癌和胃腸道癌症治療中。近距離放射治療因其能夠提供高度局部化的劑量和較短的治療時間，在子宮頸癌、前列腺癌和乳癌等癌症治療中重新引起了人們的興趣。將MRI和PET影像納入治療計畫系統，可增強腫瘤可視化和自適應治療計畫。此外，標靶放射性核治療中的新型放射性藥物正在擴大轉移性癌症（尤其是前列腺癌和神經內分泌腫瘤）的治療選擇。

醫院和癌症中心如何面對放射腫瘤學革命？

放射腫瘤科正在進行重大升級，以適應新技術、工作流程自動化和多學科整合。醫院正在投資混合手術室、先進的治療計劃軟體和腫瘤資訊系統 (OIS)，以簡化患者數據管理和治療結果追蹤。此外，放射腫瘤科醫師、醫學物理學家、劑量師和 IT 專業人員之間的合作正在正式化為跨職能團隊，以最佳化治療計劃和實施。學術醫療中心在實施 AI 引導的自適應計劃工具和雲端基礎的輪廓繪製平台方面處於主導地位，旨在縮短計劃時間並提高準確性。

培訓和員工發展也是適應的關鍵組成部分。現代放射治療的複雜性要求在影像判讀、機器校準和網路化腫瘤系統網路安全等領域不斷提陞技能。此外，醫院正在採用以患者為中心的模式，將心理社會支持、症狀追蹤和遠距會診整合到放射腫瘤科的診療路徑中。全球腫瘤網路和遠距放射平台正在幫助將先進的放射治療服務擴展到服務不足的地區，並縮小癌症治療的可及性差距。這些營運和臨床升級對於放射腫瘤科從特定程序方法向完全整合的數據主導型診療模式的演變至關重要。

放射腫瘤學市場的主要成長動力是什麼？

放射腫瘤學市場的成長受到多種因素的推動，包括全球癌症發生率的上升、放射治療技術的進步以及醫療機構對腫瘤學基礎設施的持續投資。複雜且抗治療性癌症的增多，推動了對質子治療和立體定位放射治療等精準治療的需求。同時，人工智慧、影像處理和放射治療技術的整合正在促進個人化治療計劃和療效監測，從而提高臨床療效和業務效率。

政府資助和官民合作關係正在加速已開發地區和新興地區的放射治療基礎設施建設。此外，先進放射治療的保險覆蓋範圍不斷擴大，以及人們對早期癌症檢測意識的不斷提升，也推動了該療法的廣泛應用。探索免疫療法和放射線治療新型組合的臨床試驗正在進行中，預計未來幾年將出現新的治療前沿。這些因素共同使放射腫瘤學不僅成為現代癌症治療的基石，也成為一個不斷經歷技術和臨床創新的領域，並有望在全球範圍內實現顯著成長。

部分

治療類型（外束放射線治療、近距離放射治療、全身放射線治療、立體定位放射線手術）、技術（線性加速器技術、放射性同位素技術、粒子治療技術、斷層治療技術）、用途（乳癌用途、前列腺癌用途、肺癌用途、腦腫瘤用途、頭頸癌用途）、最終用途（醫院最終用途、門診最終用途、癌症研究機構最終用途、門診手術中心最終用途

受訪公司範例

• Accuray Incorporated
• Bionix Radiation Therapy, LLC
• Brainlab AG
• Canon Medical Systems Corporation
• Curium
• Eckert & Ziegler BEBIG
• Elekta AB
• GE Healthcare
• Hitachi Ltd.
• IBA（Ion Beam Applications SA）
• Isoray Inc.
• Mevion Medical Systems Inc.
• Nanobiotix
• Nordion Inc.
• Optivus Proton Therapy Inc.
• Panacea Medical Technologies Pvt. Ltd.
• RefleXion Medical
• RaySearch Laboratories AB
• Siemens Healthineers AG
• Sirtex Medical Limited
• Varian Medical Systems（Siemens）
• ViewRay Technologies, Inc.

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 沒有查詢通用的 LLM 或特定產業的SLM，而是建立了一個來自世界各地專家的精選內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global Radiation Oncology Market to Reach US$10.2 Billion by 2030

The global market for Radiation Oncology estimated at US$7.9 Billion in the year 2024, is expected to reach US$10.2 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. External Beam Radiation Therapy, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$3.6 Billion by the end of the analysis period. Growth in the Brachytherapy segment is estimated at 5.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.2 Billion While China is Forecast to Grow at 7.6% CAGR

The Radiation Oncology market in the U.S. is estimated at US$2.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.1 Billion by the year 2030 trailing a CAGR of 7.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 3.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Radiation Oncology Market - Key Trends & Drivers Summarized

How Is Radiation Oncology Evolving in Response to Cancer Care Demands?

Radiation oncology continues to be a cornerstone in the multidisciplinary management of cancer, with ongoing innovations enhancing both efficacy and precision in targeting malignant tissues. The field has shifted significantly from conventional radiotherapy to highly advanced techniques such as intensity-modulated radiation therapy (IMRT), stereotactic radiosurgery (SRS), image-guided radiation therapy (IGRT), and proton beam therapy. These modalities allow for accurate dose delivery that spares surrounding healthy tissue, reduces side effects, and improves patient outcomes. Growing cancer incidence worldwide, coupled with an aging population, is pushing healthcare systems to expand radiation oncology infrastructure and capabilities.

The adoption of personalized oncology, where treatment is tailored based on tumor genetics and radiomic data, is further redefining treatment planning. Integration of artificial intelligence and machine learning algorithms into radiation oncology software is facilitating adaptive radiotherapy, which adjusts treatment in real time based on patient response and anatomical changes. Additionally, advancements in radiobiology and hypofractionation protocols are enabling shorter treatment durations with equal or improved efficacy, enhancing both throughput and patient convenience. These developments are driving clinical and operational transformation in radiation oncology centers globally.

Which Technologies and Modalities Are Shaping Modern Radiation Oncology Practice?

Cutting-edge technologies are transforming the landscape of radiation oncology, with linear accelerators (LINACs), proton therapy units, brachytherapy equipment, and robotic radiosurgery platforms gaining prominence. LINAC systems now incorporate multi-leaf collimators (MLCs), volumetric modulated arc therapy (VMAT), and onboard imaging to deliver precise tumor targeting in fewer sessions. Proton therapy, which deposits most of its energy at the Bragg peak, is witnessing rapid adoption in pediatric oncology and complex tumor cases due to its minimal collateral damage and reduced long-term toxicity.

Furthermore, motion management techniques such as respiratory gating and real-time tumor tracking are being incorporated to address organ movement during therapy, particularly in lung and gastrointestinal cancers. Brachytherapy is gaining renewed interest for cervical, prostate, and breast cancers, thanks to its high dose localization and shortened treatment duration. Integration of MRI and PET imaging into planning systems enhances tumor delineation and adaptive treatment planning. Additionally, emerging radiopharmaceuticals in targeted radionuclide therapy are expanding treatment options for metastatic cancers, particularly in prostate and neuroendocrine tumors.

How Are Hospitals and Cancer Centers Adapting to the Radiation Oncology Revolution?

Radiation oncology departments are undergoing significant upgrades to accommodate new technologies, workflow automation, and multidisciplinary integration. Hospitals are investing in hybrid operating suites, advanced treatment planning software, and oncology information systems (OIS) to streamline patient data management and outcome tracking. Additionally, collaborations between radiation oncologists, medical physicists, dosimetrists, and IT professionals are being formalized into cross-functional teams to optimize treatment planning and delivery. Academic medical centers are leading the charge in deploying AI-guided adaptive planning tools and cloud-based contouring platforms that enhance precision while reducing planning time.

Training and workforce development are also critical components of adaptation. The complexity of modern radiotherapy requires constant upskilling in areas such as image interpretation, machine calibration, and cybersecurity for networked oncology systems. Moreover, hospitals are adopting patient-centered models that integrate psychosocial support, symptom tracking, and remote consultations into radiation oncology care pathways. Global oncology networks and tele-radiation platforms are helping extend advanced radiotherapy services to underserved regions, reducing disparities in cancer treatment access. These operational and clinical upgrades are central to radiation oncology’s evolution from a procedural specialty into a fully integrated, data-driven care model.

What Are the Key Growth Drivers of the Radiation Oncology Market?

The growth in the radiation oncology market is driven by several factors, including the global rise in cancer prevalence, advancements in radiotherapy technologies, and increasing healthcare investments in oncology infrastructure. Rising incidence of complex and treatment-resistant cancers is propelling demand for precision-focused modalities like proton therapy and stereotactic radiotherapy. At the same time, technological convergence between AI, imaging, and radiotherapy is facilitating personalized treatment planning and outcome monitoring, which enhances clinical effectiveness and operational efficiency.

Government funding and public-private partnerships are accelerating the deployment of radiotherapy infrastructure in both developed and emerging regions. Additionally, expanding insurance coverage for advanced radiotherapy procedures and increasing awareness about early cancer detection are supporting treatment uptake. Ongoing clinical trials exploring novel combinations of immunotherapy with radiation are expected to open new therapeutic frontiers in the years ahead. Together, these drivers are positioning radiation oncology not only as a cornerstone of modern cancer therapy but also as a field undergoing continuous technological and clinical innovation, with strong growth prospects globally.

SCOPE OF STUDY:

The report analyzes the Radiation Oncology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment Type (External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy, Stereotactic Radiosurgery); Technology (Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology, Tomotherapy Technology); Application (Breast Cancer Application, Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application); End-Use (Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use, Ambulatory Surgery Centers End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

• Accuray Incorporated
• Bionix Radiation Therapy, LLC
• Brainlab AG
• Canon Medical Systems Corporation
• Curium
• Eckert & Ziegler BEBIG
• Elekta AB
• GE Healthcare
• Hitachi Ltd.
• IBA (Ion Beam Applications SA)
• Isoray Inc.
• Mevion Medical Systems Inc.
• Nanobiotix
• Nordion Inc.
• Optivus Proton Therapy Inc.
• Panacea Medical Technologies Pvt. Ltd.
• RefleXion Medical
• RaySearch Laboratories AB
• Siemens Healthineers AG
• Sirtex Medical Limited
• Varian Medical Systems (Siemens)
• ViewRay Technologies, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Radiation Oncology - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Cancer Incidence Worldwide Throws the Spotlight on Advanced Radiotherapy Modalities
  • Technological Advancements in Image-Guided Radiation Therapy Strengthen Precision Treatment Capabilities
  • Expansion of Linear Accelerator Installations in Emerging Markets Drives Equipment Uptake
  • Integration of Artificial Intelligence in Treatment Planning Accelerates Adoption of Adaptive Therapy Solutions
  • Rising Utilization of Stereotactic Radiosurgery Expands Clinical Applications in Brain and Spine Tumors
  • Growth in Proton and Heavy Ion Therapy Centers Drives Demand for High-End Oncology Infrastructure
  • Collaborations Between Research Institutions and Hospitals Fuel Personalized Oncology Approaches
  • Favorable Reimbursement Policies for Radiation Oncology Procedures Sustain Market Accessibility
  • Growing Adoption of Hypofractionated Radiotherapy Enhances Patient Convenience and Throughput
  • Emergence of Real-Time Tumor Tracking and Motion Management Improves Clinical Outcomes
  • Rising Investments in Hybrid Radiotherapy Systems Strengthen Business Case for Multi-Modality Platforms
  • Expansion of Cancer Care Networks and Outreach Programs Boosts Regional Equipment Penetration
  • Increased Focus on Pediatric Radiation Safety Drives Innovation in Dose Optimization Tools
  • Partnerships With Academic Medical Centers Accelerate Development of Evidence-Based Protocols
  • Government Grants for Cancer Treatment Infrastructure Upgrade Promote Public Hospital Modernization
  • Shift Toward Outpatient Radiotherapy Centers Enhances Equipment Turnaround and Affordability
  • Development of Cloud-Based Treatment Planning Systems Improves Workflow and Collaboration
  • Integration of Immunotherapy and Radiotherapy Approaches Strengthens Clinical Trial Pipelines
  • Surge in Awareness Campaigns on Early Cancer Detection Supports Radiation Oncology Growth
  • AI-Enabled Radiomics and Predictive Modeling Drive Precision Medicine in Radiation Treatment
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Radiation Oncology Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Radiation Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Radiation Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Radiation Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for External Beam Radiation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for External Beam Radiation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for External Beam Radiation Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Brachytherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Brachytherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Brachytherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Systemic Radiation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Systemic Radiation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Systemic Radiation Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Stereotactic Radiosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Stereotactic Radiosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Stereotactic Radiosurgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Prostate Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Prostate Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Prostate Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Lung Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Lung Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Lung Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Brain Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Brain Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Brain Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Head & Neck Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Head & Neck Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Head & Neck Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Breast Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Breast Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Breast Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Outpatient Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Outpatient Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Outpatient Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Cancer Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Cancer Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Cancer Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Linear Accelerators Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Linear Accelerators Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: World 16-Year Perspective for Linear Accelerators Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Radioisotopes Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Radioisotopes Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: World 16-Year Perspective for Radioisotopes Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 50: World Recent Past, Current & Future Analysis for Particle Therapy Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 51: World Historic Review for Particle Therapy Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: World 16-Year Perspective for Particle Therapy Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 53: World Recent Past, Current & Future Analysis for Tomotherapy Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 54: World Historic Review for Tomotherapy Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: World 16-Year Perspective for Tomotherapy Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 56: USA Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: USA Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: USA 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 59: USA Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: USA Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: USA 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 62: USA Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: USA Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: USA 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 65: USA Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: USA Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: USA 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 68: Canada Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Canada Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: Canada 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 71: Canada Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Canada Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: Canada 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 74: Canada Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Canada Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: Canada 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 77: Canada Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Canada Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: Canada 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• JAPAN
  • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 80: Japan Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Japan Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: Japan 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 83: Japan Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Japan Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: Japan 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 86: Japan Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Japan Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: Japan 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 89: Japan Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Japan Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: Japan 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• CHINA
  • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 92: China Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: China Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: China 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 95: China Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: China Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: China 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 98: China Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: China Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: China 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 101: China Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: China Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: China 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• EUROPE
  • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 104: Europe Recent Past, Current & Future Analysis for Radiation Oncology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 105: Europe Historic Review for Radiation Oncology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Europe 16-Year Perspective for Radiation Oncology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 107: Europe Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Europe Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: Europe 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 110: Europe Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Europe Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: Europe 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 113: Europe Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Europe Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: Europe 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 116: Europe Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Europe Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: Europe 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• FRANCE
  • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 119: France Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: France Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: France 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 122: France Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: France Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: France 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 125: France Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: France Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: France 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 128: France Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: France Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: France 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• GERMANY
  • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 131: Germany Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Germany Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Germany 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 134: Germany Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Germany Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Germany 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 137: Germany Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Germany Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Germany 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 140: Germany Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Germany Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Germany 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 143: Italy Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Italy Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Italy 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 146: Italy Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Italy Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Italy 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 149: Italy Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Italy Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: Italy 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 152: Italy Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Italy Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: Italy 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 155: UK Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: UK Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: UK 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 158: UK Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: UK Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: UK 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 161: UK Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: UK Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: UK 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 164: UK Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: UK Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: UK 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 167: Spain Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Spain Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: Spain 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 170: Spain Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Spain Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: Spain 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 173: Spain Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Spain Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: Spain 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 176: Spain Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Spain Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: Spain 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 179: Russia Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Russia Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: Russia 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 182: Russia Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Russia Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: Russia 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 185: Russia Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Russia Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: Russia 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 188: Russia Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Russia Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: Russia 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Europe Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: Rest of Europe 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 194: Rest of Europe Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Europe Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Rest of Europe 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 197: Rest of Europe Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Europe Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Rest of Europe 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 200: Rest of Europe Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Europe Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Rest of Europe 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Radiation Oncology by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 204: Asia-Pacific Historic Review for Radiation Oncology by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Asia-Pacific 16-Year Perspective for Radiation Oncology by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Asia-Pacific Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Asia-Pacific 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Asia-Pacific Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Asia-Pacific 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 212: Asia-Pacific Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Asia-Pacific Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Asia-Pacific 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 215: Asia-Pacific Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Asia-Pacific Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: Asia-Pacific 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 218: Australia Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Australia Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: Australia 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 221: Australia Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Australia Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: Australia 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 224: Australia Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Australia Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: Australia 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 227: Australia Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Australia Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: Australia 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• INDIA
  • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 230: India Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: India Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: India 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 233: India Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: India Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: India 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 236: India Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: India Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: India 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 239: India Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: India Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: India 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 242: South Korea Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: South Korea Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: South Korea 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 245: South Korea Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: South Korea Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: South Korea 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 248: South Korea Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: South Korea Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: South Korea 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 251: South Korea Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: South Korea Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: South Korea 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Rest of Asia-Pacific Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Rest of Asia-Pacific 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 257: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Rest of Asia-Pacific Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Rest of Asia-Pacific 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 260: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Rest of Asia-Pacific Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Rest of Asia-Pacific 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 263: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Rest of Asia-Pacific Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Rest of Asia-Pacific 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 266: Latin America Recent Past, Current & Future Analysis for Radiation Oncology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 267: Latin America Historic Review for Radiation Oncology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Latin America 16-Year Perspective for Radiation Oncology by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 269: Latin America Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Latin America Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Latin America 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 272: Latin America Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Latin America Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Latin America 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 275: Latin America Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Latin America Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: Latin America 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 278: Latin America Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Latin America Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: Latin America 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 281: Argentina Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Argentina Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: Argentina 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 284: Argentina Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Argentina Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: Argentina 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 287: Argentina Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Argentina Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: Argentina 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 290: Argentina Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Argentina Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: Argentina 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 293: Brazil Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Brazil Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: Brazil 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 296: Brazil Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Brazil Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: Brazil 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 299: Brazil Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Brazil Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: Brazil 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 302: Brazil Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Brazil Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 304: Brazil 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 305: Mexico Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Mexico Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 307: Mexico 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 308: Mexico Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Mexico Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 310: Mexico 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 311: Mexico Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Mexico Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 313: Mexico 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 314: Mexico Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Mexico Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 316: Mexico 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Rest of Latin America Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 319: Rest of Latin America 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 320: Rest of Latin America Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Rest of Latin America Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 322: Rest of Latin America 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 323: Rest of Latin America Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Rest of Latin America Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 325: Rest of Latin America 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 326: Rest of Latin America Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Rest of Latin America Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 328: Rest of Latin America 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 329: Middle East Recent Past, Current & Future Analysis for Radiation Oncology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 330: Middle East Historic Review for Radiation Oncology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 331: Middle East 16-Year Perspective for Radiation Oncology by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 332: Middle East Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Middle East Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 334: Middle East 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 335: Middle East Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Middle East Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 337: Middle East 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 338: Middle East Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Middle East Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 340: Middle East 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 341: Middle East Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Middle East Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 343: Middle East 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 344: Iran Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Iran Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 346: Iran 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 347: Iran Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Iran Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 349: Iran 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 350: Iran Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Iran Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 352: Iran 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 353: Iran Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Iran Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 355: Iran 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 356: Israel Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Israel Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 358: Israel 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 359: Israel Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Israel Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 361: Israel 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 362: Israel Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Israel Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 364: Israel 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 365: Israel Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Israel Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 367: Israel 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Saudi Arabia Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 370: Saudi Arabia 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 371: Saudi Arabia Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Saudi Arabia Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 373: Saudi Arabia 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 374: Saudi Arabia Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Saudi Arabia Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 376: Saudi Arabia 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 377: Saudi Arabia Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Saudi Arabia Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 379: Saudi Arabia 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 380: UAE Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: UAE Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 382: UAE 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 383: UAE Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: UAE Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 385: UAE 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 386: UAE Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: UAE Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 388: UAE 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 389: UAE Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: UAE Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 391: UAE 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Rest of Middle East Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 394: Rest of Middle East 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 395: Rest of Middle East Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Rest of Middle East Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 397: Rest of Middle East 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 398: Rest of Middle East Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Rest of Middle East Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 400: Rest of Middle East 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 401: Rest of Middle East Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Rest of Middle East Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 403: Rest of Middle East 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
• AFRICA
  • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 404: Africa Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Africa Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 406: Africa 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
  • TABLE 407: Africa Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 408: Africa Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 409: Africa 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
  • TABLE 410: Africa Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 411: Africa Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 412: Africa 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • TABLE 413: Africa Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 414: Africa Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 415: Africa 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030

IV. COMPETITION